Sextant Core Fund GSK Holdings History
Sextant Core Fund's GSK PLC Holding Summary
As of 2025-02-28, SATURNA INVESTMENT TRUST held 4,200.00 shares of GSK PLC(GSK), totaling $157,880.00. This investment constitutes 0.98% of their stock portfolio, and SATURNA INVESTMENT TRUST now holds 0% of the outstanding GSK PLC(GSK) stock.
The initial trade took place in 2023Q4. And since then Sextant Core Fund has made 4 purchases of GSK, at an average price of $38.11, for a total of 9,250.00 shares. In addition, there have been 2 sales at an average price of $36.73 for 5,050.00 shares. Based on historical transaction data and GSK's current price of $38.23, Sextant Core Fund's estimated gain on his GSK holdings is $-6,473.50, reflecting a -1.84% gain to date.
Sextant Core Fund GSK ($38.23) Holding Chart
Sextant Core Fund GSK ($38.23) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
